Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study
- 10 June 2020
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 105 (3), 432-439
- https://doi.org/10.1136/bjophthalmol-2020-316030
Abstract
Background To estimate the 10-year incidence of referable diabetic retinopathy (DR) in a French population with type 1 and 2 diabetes mellitus (DM). A secondary objective was the assessment of safe screening intervals in patients with diabetes without retinopathy. Methods Observational, prospective and multicentric study between June 2004 and September 2017 based on a regional screening programme for DR in the Paris region. The incidence of referable DR in patients without retinopathy at baseline was calculated by the Turnbull survival estimator. A safe screening interval was defined as a 95% probability of remaining without referable DR. Results Among the 25 745 participants with type 1 (n=6086) or type 2 (n=19 659) DM, the 10-year cumulative incidence of referable DR was 19.10% (95% CI 17.21% to 21.14%) and 17.03% (15.78% to 18.35%), median (IQR) follow-up=3.33 (4.24) years. The safe screening interval for patients without DR at the first examination for type 1 and 2 DM was 2.2 (95% CI 2.0 to 2.4) and 3.0 (2.9 to 3.1) years, respectively. In a subgroup of low-risk patients with type 2 DM, the safe screening interval was 4.2 (3.8 to 4.6) years. Conclusions These data suggest that in Paris area, a 2-year, 3-year and 4-year screening interval was considered safe for type 1 DM, type 2 DM and for low-risk patients with type 2 DM, respectively, without DR at the first examination. While these data might be used to support the consideration of extending screening intervals, a randomised clinical trial would be suitable to confirm the safety for patients with DM.Keywords
Funding Information
- Club Francophone des Specialistes de la Retine
This publication has 29 references indexed in Scilit:
- Epidemiology of diabetic retinopathy, diabetic macular edema and related vision lossEye and Vision, 2015
- Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysisBMJ, 2012
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Incidence and Progression of Diabetic Retinopathy During 17 Years of a Population-Based Screening Program in EnglandDiabetes Care, 2012
- Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without RetinopathyDiabetes Care, 2011
- Diabetic retinopathy screening: a systematic review of the economic evidenceDiabetic Medicine, 2010
- Epidemiology of diabetic retinopathy: Expected vs reported prevalence of cases in the French populationDiabetes & Metabolism, 2009
- OPHDIAT©: A telemedical network screening system for diabetic retinopathy in the Île-de-FranceDiabetes & Metabolism, 2008
- Declaración de la Iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionalesGaceta Sanitaria, 2008
- Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology, 2003